Dr. R. Corey Waller argues that toxicology testing is essential in addiction care, providing objective data to detect substances, guide treatment, and improve safety. Used correctly with consent and non-punitive policies, it saves lives and protects both patients and providers.

State Laws Banning Prior Authorization For Medications For Opioid Use Disorder

Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine

Ultra-processed food addiction

Gambling Disorder in the Age of Mobile Sports Betting

Online gambling is a rapidly growing industry all over the world, affecting both adults and youth. By providing evidence-supported interventions for prevention and treatment, practitioners can help ensure that the rapid growth of mobile betting is matched by a rapid, sophisticated public health response.

Measures of General Intelligence and Risk for Alcohol Use

Medications for Opioid Use Disorder Playbook

Cannabis Use During Pregnancy and Lactation

Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compounds

Evaluation of a Novel Patient-Centered Methadone Restart Protocol

Recommendations for Addressing In-Hospital Substance Use

Injectable-Only Overlapping Buprenorphine Starting Protocol

Guest Editorial: A Reality Check

Guest Editorial: One of These Things Is Not Like the Others

The opioid crisis remains a critical public health issue in the United States, contributing to over 80,000 opioid overdose deaths in 2023 alone.

Guest Editorial: Reconceptualizing Recovery: Findings from the National Survey on Drug Use and Health

This article highlights findings from the 2022 NSDUH showing that many Americans in recovery from substance use continue to use alcohol or other drugs, challenging the abstinence-only model that dominates U.S. treatment. The study found no significant differences in functioning between abstinent and nonabstinent individuals in recovery, underscoring the need to broaden definitions of recovery and incorporate harm reduction approaches. The authors advocate for more inclusive, flexible treatment models that align with individuals’ goals, reduce stigma, and improve service engagement and outcomes.

Co-involvement of stimulants with opioids in North America: A 'silent epidemic’

Did alcohol facilitate the evolution of complex societies?